Liver transplant recipients with hepatitis B may need lifelong antiviral treatment
Thursday, February 26, 2009 - 13:07
in Health & Medicine
Patients who undergo liver transplantation for hepatitis B-related liver damage should receive lifelong antiviral treatment to keep the disease from coming back. A new study shows that they lack cellular immunity against the disease, making recurrence likely if antiviral treatment is withdrawn. These findings are in the March issue of Liver Transplantation.